We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHMI
3176
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
$87K ﹤0.01%
+17,826
New +$117K
GRTS
3177
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$87K ﹤0.01%
33,616
-80,418
-71% -$256K
ARC
3178
DELISTED
ARC Document Solutions, Inc.
ARC
$85K ﹤0.01%
+37,604
New +$105K
LWLG icon
3179
Lightwave Logic
LWLG
$945M
$84K ﹤0.01%
11,500
-312,728
-96% -$2.93M
PDSB icon
3180
PDS Biotechnology
PDSB
$38.7M
$82K ﹤0.01%
27,598
-49,147
-64% -$209K
PG icon
3181
Procter & Gamble
PG
$346B
$79K ﹤0.01%
627
-818,261
-100% -$116M
TSQ icon
3182
Townsquare Media
TSQ
$106M
$79K ﹤0.01%
+10,902
New +$92.5K
IMUX icon
3183
Immunic
IMUX
$188M
$77K ﹤0.01%
+2,437
New +$102K
RCEL icon
3184
Avita Medical
RCEL
$146M
$77K ﹤0.01%
+14,491
New +$89.5K
CDZI icon
3185
Cadiz
CDZI
$259M
$75K ﹤0.01%
39,423
-70,702
-64% -$238K
DAVE icon
3186
Dave Inc
DAVE
$5.16B
$75K ﹤0.01%
6,605
+5,088
+335% +$94K
NRGV icon
3187
Energy Vault
NRGV
$531M
$74K ﹤0.01%
+14,100
New +$76.6K
ICD
3188
DELISTED
Independence Contract Drilling, Inc.
ICD
$73K ﹤0.01%
24,265
-2,776
-10% -$8.9K
SURG icon
3189
SurgePays
SURG
$6.08M
$72K ﹤0.01%
+15,829
New +$80.8K
CCAC.WS
3190
CALL
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
$72K ﹤0.01%
342,872
-154,937
-31% -$32.5K
CSSEL
3191
CALL
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Warrant
CSSEL
$71K ﹤0.01%
+10,409
New +$1.05K
AEVA
3192
Aeva Technologies
AEVA
$1.06B
$70K ﹤0.01%
7,462
-4,327
-37% -$68.3K
CIFR icon
3193
Cipher Digital
CIFR
$8.86B
$69K ﹤0.01%
55,186
TGL icon
3194
Treasure Global
TGL
$6.26M
0
MKFG
3195
DELISTED
Markforged Holding Corporation
MKFG
$68K ﹤0.01%
3,452
-31,176
-90% -$722K
KODK icon
3196
Kodak
KODK
$788M
$66K ﹤0.01%
14,245
-417,922
-97% -$2.28M
NUVB icon
3197
Nuvation Bio
NUVB
$2.32B
$65K ﹤0.01%
29,111
NUE icon
3198
PUT
Nucor
NUE
$56.4B
$64K ﹤0.01%
+600
New +$75.3K
DADA
3199
DELISTED
Dada Nexus
DADA
$61K ﹤0.01%
+12,631
New +$83.4K
STSA
3200
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$61K ﹤0.01%
+10,123
New +$57.4K

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.